1. Letter From the Commissioner’s Office at the US FDA

   • John A. Vernon

   Editorial 22 September 2012 Pages: 89 - 90

2. Is Medication Review by Pharmacists of Any Use?

   • Arnold G. Zermansky
   • Nick Freemantle

   Editorial 22 September 2012 Pages: 91 - 92

3. Measuring Preferences for Cost-Utility Analysis

   • Christine M. McDonough
   • Anna N. A. Tosteson

   Current Opinion 22 September 2012 Pages: 93 - 106

   

4. A ‘League Table’ of Contingent Valuation Results for Pharmaceutical Interventions

   • Tracey H. Sach
   • Richard D. Smith
   • David K. Whynes

   Review Article 22 September 2012 Pages: 107 - 127

   

5. Disease Burden of Overactive Bladder

   • Ramandeep Basra
   • Con Kelleher

   Review Article 22 September 2012 Pages: 129 - 142

   

6. Conjoint Analysis of French and German Parents’ Willingness to Pay for Meningococcal Vaccine

   • David Bishai
   • Roger Brice
   • Jenifer Ehreth

   Original Research Article 22 September 2012 Pages: 143 - 154

   

7. Acute/Subacute Herpes Zoster

   • Ralph P. Insinga
   • Robbin F. Itzler
   • James M. Pellissier

   Original Research Article 22 September 2012 Pages: 155 - 169

   

8. Home-Based Medication Review in Older People

   • Margaret Pacini
   • Richard D. Smith
   • Richard Holland

   Original Research Article 22 September 2012 Pages: 171 - 180